These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1800411)

  • 1. Model-based comparisons of measles immunization strategies using high dose Edmonston-Zagreb type vaccines.
    McLean AR; Nokes DJ; Anderson RM
    Int J Epidemiol; 1991 Dec; 20(4):1107-17. PubMed ID: 1800411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization of six-month-old infants with different doses of Edmonston-Zagreb and Schwarz measles vaccines.
    Markowitz LE; Sepulveda J; Diaz-Ortega JL; Valdespino JL; Albrecht P; Zell ER; Stewart J; Zarate ML; Bernier RH
    N Engl J Med; 1990 Mar; 322(9):580-7. PubMed ID: 2304505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trial of Edmonston-Zagreb measles vaccine in infants aged under nine months.
    Pongrithsukda V; Gluck R; Suwatanapongched S; Kaewmalung P; Muyakul J
    Southeast Asian J Trop Med Public Health; 1991 Sep; 22(3):347-50. PubMed ID: 1818384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful immunization of infants at 6 months of age with high dose Edmonston-Zagreb measles vaccine. Cite Soleil/JHU Project Team.
    Job JS; Halsey NA; Boulos R; Holt E; Farrell D; Albrecht P; Brutus JR; Adrien M; Andre J; Chan E
    Pediatr Infect Dis J; 1991 Apr; 10(4):303-11. PubMed ID: 2062626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization of young infants with Edmonston-Zagreb measles vaccine.
    Markowitz LE; Bernier RH
    Pediatr Infect Dis J; 1987 Sep; 6(9):809-12. PubMed ID: 3313247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measles immunization strategies for countries with high transmission rates: interim guidelines predicted using a mathematical model.
    Nokes DJ; McLean AR; Anderson RM; Grabowsky M
    Int J Epidemiol; 1990 Sep; 19(3):703-10. PubMed ID: 2262268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expanded programme on immunization (EPI). Safety of high titre measles vaccines.
    Wkly Epidemiol Rec; 1992 Nov; 67(48):357-61. PubMed ID: 1449986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lessons from measles vaccination in developing countries.
    Hall AJ; Cutts FT
    BMJ; 1993 Nov; 307(6915):1294-5. PubMed ID: 8257878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Head-to-head immunogenicity comparison of Edmonston-Zagreb vs. AIK-C measles vaccine strains in infants aged 8-12 months: A randomized clinical trial.
    Izadi S; Zahraei SM; Salehi M; Mohammadi M; Tabatabaei SM; Mokhtari-Azad T
    Vaccine; 2018 Jan; 36(5):631-636. PubMed ID: 29289382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of efficacy of the standard potency Edmonston-Zagreb live, attenuated measles vaccine in African infants.
    Kiepiela P; Coovadia HM; Loening WE; Coward P; Botha G; Hugo J; Becker PJ
    Bull World Health Organ; 1991; 69(2):221-7. PubMed ID: 1860150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative serological efficacy of the measles vaccine strains Edmonston-Zagreb, Schwarz and AIK-C in Togolese infants of 4-5 months and 8-10 months].
    Tidjani O; Grunitzky B; Guérin N; Lévy-Bruhl D; Lecam N; Xuereff C; Tatagan K
    Bull Soc Pathol Exot; 1991; 84(5 Pt 5):873-84. PubMed ID: 1819435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling the Transmission of Measles and Rubella to Support Global Management Policy Analyses and Eradication Investment Cases.
    Thompson KM; Badizadegan ND
    Risk Anal; 2017 Jun; 37(6):1109-1131. PubMed ID: 28561947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measles antibody levels after vaccination with Edmonston-Zagreb and Schwarz measles vaccine at 9 months or at 9 and 18 months of age: a serological study within a randomised trial of different measles vaccines.
    Martins C; Garly ML; Bale C; Rodrigues A; Benn CS; Whittle H; Aaby P
    Vaccine; 2013 Nov; 31(48):5766-71. PubMed ID: 23994379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measles in infants: a review of studies on incidence, vaccine efficacy and mortality in east Africa.
    Burström B; Aaby P; Mutie DM
    East Afr Med J; 1995 Mar; 72(3):155-61. PubMed ID: 7796766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity of aerosol measles vaccine given as the primary measles immunization to nine-month-old Mexican children.
    Wong-Chew RM; Islas-Romero R; García-García Mde L; Beeler JA; Audet S; Santos-Preciado JI; Gans H; Lew-Yasukawa L; Maldonado YA; Arvin AM; Valdespino-Gómez JL
    Vaccine; 2006 Jan; 24(5):683-90. PubMed ID: 16154241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of dose and strain of live attenuated measles vaccines on serological responses in young infants.
    Cutts FT; Grabowsky M; Markowitz LE
    Biologicals; 1995 Mar; 23(1):95-106. PubMed ID: 7619443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Edmonston-Zagreb, Connaught and Schwarz measles vaccines in Cameroonian infants aged 3-8 months.
    Ndumbe PM; Gilchrist SA; Pabst H; Sama MT; Mbede J
    Vaccine; 1995 Feb; 13(3):276-80. PubMed ID: 7631514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immuno-epidemiologic considerations on the prevention of measles in Mexico].
    Díaz-Ortega JL; Valdespino-Gómez JL; Zárate-Aquino ML; Camacho-Amor ML; González-Velázquez MS; Chávez-San Juan R
    Bol Med Hosp Infant Mex; 1990 Jul; 47(7):474-81. PubMed ID: 2206412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized trial of a standard dose of Edmonston-Zagreb measles vaccine given at 4.5 months of age: effect on total hospital admissions.
    Martins CL; Benn CS; Andersen A; Balé C; Schaltz-Buchholzer F; Do VA; Rodrigues A; Aaby P; Ravn H; Whittle H; Garly ML
    J Infect Dis; 2014 Jun; 209(11):1731-8. PubMed ID: 24436454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective efficacy of standard Edmonston-Zagreb measles vaccination in infants aged 4.5 months: interim analysis of a randomised clinical trial.
    Martins CL; Garly ML; Balé C; Rodrigues A; Ravn H; Whittle HC; Lisse IM; Aaby P
    BMJ; 2008 Jul; 337():a661. PubMed ID: 18653640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.